Both in Pharmaceuticals
Unicycive Therapeutics vs Perspective Therapeutics
Over the past year UNCY returned −15.5% and CATX returned −62.7%; their daily moves had a correlation of 0.25.
UNCY −15.5% CATX −62.7%Growth of $1, one year, split-adjusted
| Metric | UNCY | CATX |
|---|---|---|
| Price | $3.75 | $0.8702 |
| Market cap | $104.5M | $99.3M |
| Today | +4.46% | −1.11% |
| 1 month | −11.3% | −63.1% |
| 6 months | −53.9% | −77.2% |
| Year to date | −35.0% | −68.4% |
| 1 year | −15.5% | −66.5% |
| Revenue growth (YoY) | — | −72.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −33069.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 242.9× |
| Net cash | $61.4M | $235.3M |
| Dividend yield | — | — |
| Volatility (60d) | 56.7% | 117.1% |
| Short % of float | 17.8% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).